Sign in

CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

AN2 Therapeutics, Inc.

Sign in to watch
Ticker
ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
820606654
Phone
(650) 331-9090
Business address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
  1. SCHEDULE 13D Stake Beneficial Ownership Report
  2. 8-K Event Regulation FD disclosure
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. ARS Other Annual Report to Security Holders
  8. DEFA14A Proxy Proxy Materials
  9. DEF 14A Proxy Proxy Statement
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 7 of 20 · 387 filings